Delayed HIV treatment initiation, use of protease inhibitors for more than a year, tobacco use and sleep apnoea increase the odds of erectile dysfunction among cisgender men living with HIV, according to the findings of the US Military HIV Natural History Study (NHS), published in HIV Medicine. Although HIV is associated with an increased risk… Read More »
A US study has concluded that weight gain is greater by around 2 to 4kg in HIV-positive people taking bictegravir or dolutegravir as part of their first antiretroviral therapy (ART), compared to their counterparts using other drug regimens. A similar effect was reported in those using the protease inhibitor darunavir. The study led by Dr… Read More »
FDA Approves Sevenfact [coagulation factor VIIa (recombinant)-jncw] for Treatment and Control of Bleeding Episodes Occurring in Adult and Adolescent Hemophilia A and B Patients with Inhibitors Print this page LOUISVILLE, Ky., April 6, 2020 /PRNewswire/ — HEMA Biologics, LLC, (“HEMA Biologics”) today announced that the U.S. Food and Drug Administration (FDA) approved Sevenfact® [coagulation factor… Read More »